ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,224,000 | -20.8% | 6,552,068 | 0.0% | 4.23% | -11.9% |
| Q2 2022 | $7,862,000 | -8.4% | 6,552,068 | 0.0% | 4.80% | -0.5% |
| Q1 2022 | $8,583,000 | -25.6% | 6,552,068 | 0.0% | 4.82% | -35.4% |
| Q4 2021 | $11,532,000 | -18.9% | 6,552,068 | 0.0% | 7.47% | -7.0% |
| Q3 2021 | $14,218,000 | -38.0% | 6,552,068 | 0.0% | 8.03% | +374.2% |
| Q2 2021 | $22,932,000 | -64.5% | 6,552,068 | 0.0% | 1.69% | -93.7% |
| Q1 2021 | $64,603,000 | +16.8% | 6,552,068 | +28.4% | 26.69% | -0.2% |
| Q4 2020 | $55,303,000 | +30.6% | 5,101,787 | +24.1% | 26.73% | -10.2% |
| Q3 2020 | $42,332,000 | -50.7% | 4,109,867 | -0.1% | 29.76% | -30.3% |
| Q2 2020 | $85,866,000 | +113.7% | 4,112,355 | 0.0% | 42.72% | +22.7% |
| Q1 2020 | $40,178,000 | -13.7% | 4,112,355 | +1.7% | 34.81% | -27.2% |
| Q4 2019 | $46,578,000 | – | 4,043,212 | – | 47.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |